Fact · Accessibility and health
Compared with no active treatment, splinting may provide little or no benefit in symptoms in the short term.
Checked against its source on October 16, 2026
In the source's own words
“splinting may provide little or no benefits in symptoms in the short term”
Splinting for carpal tunnel syndrome (Cochrane review, 2023), Karjalainen TV et al., Cochrane Database of Systematic Reviews, 2023, Main results.
Open the original- What it measures
- The review defines the short term as under three months. The authors graded this comparison as low-certainty evidence.
- What it does not show
- The review also says a small improvement cannot be ruled out. It says the clinical importance of any improvement is unclear.